Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Amylyx Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Exercised 18,165 options to buy
@ $6.88, valued at
$125k
|
|
| 08/17/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Gifted 2,000,000 shares
@ $0 |
|
| 08/17/2023 |
4
| Mazzariello Gina (Chief Legal Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 6,164 shares
@ $20.8771, valued at
$128.7k
|
|
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2023 |
4
| Firestone Karen (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 3,908 options to buy
@ $26.25, valued at
$102.6k
|
|
| 06/12/2023 |
4
| MILNE GEORGE M JR (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 16,985 options to buy
@ $26.25, valued at
$445.9k
|
|
| 06/12/2023 |
4
| Quimi Daphne (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 16,985 options to buy
@ $26.25, valued at
$445.9k
|
|
| 06/12/2023 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 16,985 options to buy
@ $26.25, valued at
$445.9k
|
|
| 05/24/2023 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Gifted 1,580 shares
@ $0 |
|
| 05/19/2023 |
4
| Mazzariello Gina (Chief Legal Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Gifted 500 shares
@ $0 |
|
| 05/18/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 32,000 shares
@ $26.9266, valued at
$861.7k
Sold 500 shares
@ $27.6, valued at
$13.8k
Exercised 32,500 options to buy
@ $6.88, valued at
$223.6k
|
|
| 05/17/2023 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 11,965 shares
@ $29.0312, valued at
$347.4k
Exercised 2,201 options to buy
@ $0.37, valued at
$814.4
Exercised 9,764 options to buy
@ $6.88, valued at
$67.2k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 29,048 shares
@ $30.45, valued at
$884.5k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 34,641 shares
@ $31.69, valued at
$1.1M
Sold 28,807 shares
@ $32.17, valued at
$926.7k
|
|
| 03/20/2023 |
4
| Klee Justin B. (Co-CEO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 96,555 shares
@ $31.8405, valued at
$3.1M
Sold 3,445 shares
@ $32.4751, valued at
$111.9k
Granted 50,000 shares
@ $0
Granted 225,000 options to buy
@ $32.08, valued at
$7.2M
|
|
| 03/20/2023 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 18,333 shares
@ $0
Granted 82,500 options to buy
@ $32.08, valued at
$2.6M
|
|
| 03/20/2023 |
4
| MILNE GEORGE M JR (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 33,084 shares
@ $31.8553, valued at
$1.1M
Sold 1,916 shares
@ $32.4487, valued at
$62.2k
|
|
| 03/20/2023 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 52,211 shares
@ $31.8485, valued at
$1.7M
Sold 2,416 shares
@ $32.4331, valued at
$78.4k
Granted 9,167 shares
@ $0
Granted 41,250 options to buy
@ $32.08, valued at
$1.3M
|
|
| 03/20/2023 |
4
| Mazzariello Gina (Chief Legal Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 18,333 shares
@ $0
Granted 82,500 options to buy
@ $32.08, valued at
$2.6M
|
|
| 03/20/2023 |
4
| Firestone Karen (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $31.99, valued at
$32k
Granted 27,403 options to buy
@ $32.08, valued at
$879.1k
|
|
| 03/20/2023 |
4
| Cohen Joshua B (Co-CEO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 96,076 shares
@ $31.8396, valued at
$3.1M
Sold 3,924 shares
@ $32.4451, valued at
$127.3k
Granted 50,000 shares
@ $0
Granted 225,000 options to buy
@ $32.08, valued at
$7.2M
|
|
| 03/20/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 30,796 shares
@ $31.8593, valued at
$981.1k
Sold 1,704 shares
@ $32.4649, valued at
$55.3k
Granted 21,667 shares
@ $0
Granted 97,500 options to buy
@ $32.08, valued at
$3.1M
|
|
| 03/17/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 9,122 shares
@ $32.55, valued at
$296.9k
|
|
| 03/16/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 70,714 shares
@ $34.54, valued at
$2.4M
Sold 108,934 shares
@ $33.12, valued at
$3.6M
Sold 41,066 shares
@ $33.68, valued at
$1.4M
|
|
| 03/06/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 50,000 shares
@ $33.75, valued at
$1.7M
|
|
| 02/28/2023 |
4
| Mazzariello Gina (Chief Legal Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 3,586 shares
@ $34.4874, valued at
$123.7k
|
|
| 02/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 39,916 shares
@ $35.91, valued at
$1.4M
Sold 10,084 shares
@ $36.34, valued at
$366.5k
Sold 48,889 shares
@ $35.55, valued at
$1.7M
Sold 1,111 shares
@ $36.24, valued at
$40.3k
|
|
| 01/10/2023 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 1,405 shares
@ $36.0789, valued at
$50.7k
Sold 629 shares
@ $36.7888, valued at
$23.1k
|
|
| 01/10/2023 |
4
| Cohen Joshua B (Co-CEO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 4,122 shares
@ $36.0789, valued at
$148.7k
Sold 1,846 shares
@ $36.7888, valued at
$67.9k
|
|
| 01/10/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 1,836 shares
@ $36.0789, valued at
$66.2k
Sold 822 shares
@ $36.7888, valued at
$30.2k
|
|
| 01/10/2023 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 1,660 shares
@ $36.0789, valued at
$59.9k
Sold 743 shares
@ $36.7888, valued at
$27.3k
|
|
|
|
|